Follow the Latest News from IMS

Myeloma SocietyFollow

Myeloma Society
Myeloma_SocietyMyeloma Society@Myeloma_Society·
31 Jul

It’s the best time of year to visit Vienna and come together with other professionals from the international myeloma community. If you can’t make it to the in-person event, you can still join us virtually! Learn more and register here: https://bit.ly/3ibfhxu #IMW2021

Reply on Twitter 1421500942189477890Retweet on Twitter 1421500942189477890Like on Twitter 14215009421894778902Twitter 1421500942189477890
Myeloma_SocietyMyeloma Society@Myeloma_Society·
28 Jul

Abstracts for research with late-breaking results will be considered from Thursday, July 22 through Thursday, August 5. Authors will be notified of selection on Friday, August 13. Make sure to submit your abstract before it's too late! Submit now: https://bit.ly/3f6KP5A #IMW2021

Reply on Twitter 1420421311470391296Retweet on Twitter 1420421311470391296Like on Twitter 1420421311470391296Twitter 1420421311470391296
Myeloma_SocietyMyeloma Society@Myeloma_Society·
22 Jul

COVID-19 in MM: what we have learned?
Don’t miss this panel discussion as we dig into the effect of COVID-19 on our profession and treatment of patients, moderated by Drs. Karthik Ramasamy and Douglas Joshua. Find out more info here: https://bit.ly/3eE7tln #IMW2021

Reply on Twitter 1418216779545911302Retweet on Twitter 14182167795459113025Like on Twitter 141821677954591130214Twitter 1418216779545911302
Myeloma_SocietyMyeloma Society@Myeloma_Society·
21 Jul

Register today for @Myeloma_Society #IMW2021 in #Vienna September 8-11! For more details: http://ow.ly/mNDQ50FvXkt

Reply on Twitter 1417967681446334473Retweet on Twitter 14179676814463344733Like on Twitter 14179676814463344735Twitter 1417967681446334473
Myeloma_SocietyMyeloma Society@Myeloma_Society·
19 Jul

The IMS gratefully acknowledges the following organizations for their sponsorship of the 18th International Myeloma Workshop! https://bit.ly/3i9xMRw #IMW2021
@Amgen @GSK @OncopeptidesUS @sanofi @TakedaPharma @bmsnews @JanssenOncUS

Reply on Twitter 1417182510618918918Retweet on Twitter 14171825106189189183Like on Twitter 141718251061891891811Twitter 1417182510618918918
Myeloma_SocietyMyeloma Society@Myeloma_Society·
17 Jul

Vienna is ready to host a successful 18th International Myeloma Workshop from September 8-11, 2021 in Vienna, Austria. For those who choose not to travel, #IMW2021 will be taking place virtually as well! Find rates and register today here >> https://bit.ly/36HEEjP

Reply on Twitter 1416416157490352128Retweet on Twitter 14164161574903521288Like on Twitter 141641615749035212817Twitter 1416416157490352128
Myeloma_SocietyMyeloma Society@Myeloma_Society·
15 Jul

30+ learning opportunities await you in Vienna!
Led by the #IMW2021 Scientific Program Committee, the four-day program is comprised of 30+ exceptional scientific education opportunities focused on the basic, preclinical and clinical aspects of myeloma https://bit.ly/3xHQ2rG

Reply on Twitter 1415740459452936192Retweet on Twitter 141574045945293619211Like on Twitter 141574045945293619218Twitter 1415740459452936192
Myeloma_SocietyMyeloma Society@Myeloma_Society·
14 Jul

Register today for @Myeloma_Society #IMW2021 in #Vienna September 8-11! Details can be found here http://ow.ly/mNDQ50FvXkt

Reply on Twitter 1415341582518300677Retweet on Twitter 1415341582518300677Like on Twitter 14153415825183006772Twitter 1415341582518300677
Myeloma_SocietyMyeloma Society@Myeloma_Society·
11 Jul

The deadline for submitting abstracts for #IMW2021 is TODAY. Remember to upload yours by 11:59 PM PST! More details can be found here: http://ow.ly/jDCS50Fts5n

Reply on Twitter 1414222981463777280Retweet on Twitter 14142229814637772805Like on Twitter 14142229814637772806Twitter 1414222981463777280
Myeloma_SocietyMyeloma Society@Myeloma_Society·
8 Jul

It's not too late to submit your abstract for #IMW21. Final deadline is July 11! Learn more here: http://ow.ly/P7Fm50Fe3BQ

Reply on Twitter 1413181150328147971Retweet on Twitter 14131811503281479712Like on Twitter 14131811503281479716Twitter 1413181150328147971
Myeloma_SocietyMyeloma Society@Myeloma_Society·
6 May

The 2nd Immune Effector Cell Therapies in Multiple Myeloma Workshop begins tomorrow Learn more here: http://ow.ly/M41950EEBEZ

Reply on Twitter 1390335649094451206Retweet on Twitter 1390335649094451206Like on Twitter 13903356490944512064Twitter 1390335649094451206
Myeloma_SocietyMyeloma Society@Myeloma_Society·
4 May

There's still time to register for the @Myeloma_Society 2nd Immune Effector Cell Therapies in MM workshop. Meet in-person in #Boston or participate virtually May 7-8! Learn more here: http://ow.ly/M41950EEBEZ

Reply on Twitter 1389641030765617155Retweet on Twitter 13896410307656171552Like on Twitter 13896410307656171555Twitter 1389641030765617155
Myeloma_SocietyMyeloma Society@Myeloma_Society·
30 Apr

Register today for the @Myeloma_Society 2nd Immune Effector Cell Therapies in MM Workshop May 7-8, 2021. Learn more here: http://ow.ly/UPcS50EC1Wp

Reply on Twitter 1388209048458248192Retweet on Twitter 13882090484582481923Like on Twitter 13882090484582481925Twitter 1388209048458248192
Myeloma_SocietyMyeloma Society@Myeloma_Society·
20 Apr

Register today for @Myeloma_Society 2nd Immune Effector Cell Therapy in Multiple Myeloma Workshop May 7-8!
Learn more here: https://www.myelomasociety.org/events/2nd-immune-effector-cell-therapy-in-multiple-myeloma-workshop/

Reply on Twitter 1384538615364132864Retweet on Twitter 13845386153641328642Like on Twitter 13845386153641328645Twitter 1384538615364132864
Myeloma_SocietyMyeloma Society@Myeloma_Society·
30 Mar

Register today for @Myeloma_Society 2nd Immune Effector Cell Therapy in Multiple Myeloma Workshop May 7-8!
Learn more here: https://www.myelomasociety.org/meetings/upcoming-meetings.php

Reply on Twitter 1376957481063186432Retweet on Twitter 13769574810631864324Like on Twitter 13769574810631864329Twitter 1376957481063186432
Retweet on TwitterMyeloma Society Retweeted
VincentRKVincent Rajkumar@VincentRK·
27 Mar

Breaking News: lde-cel (Abecma; idecabtagene vicleucel), approved by FDA for multiple myeloma.

This is the first CAR-T therapy for myeloma. Many patients have been waiting for this good news. @agarwalonc @BMS_Myeloma_US @bluebirdbio https://news.bms.com/news/corporate-financial/2021/U.S.-Food-and-Drug-Administration-Approves-Bristol-Myers-Squibbs-and-bluebird-bios-Abecma-idecabtagene-vicleucel-the-First-Anti-BCMA-CAR-T-Cell-Therapy-for-Relapsed-or-Refractory-Multiple-Myeloma/default.aspx

Reply on Twitter 1375647525160517632Retweet on Twitter 137564752516051763290Like on Twitter 1375647525160517632259Twitter 1375647525160517632
Load More...

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

See All of the Member Benefits
Become a Member Today

Stay updated on our Events